TRDA

TRDA Operating Cash Flow (Statement)

-$134.67MTTM · USD

Period ending:

TRDA FY Cash from OperationsUSD
TRDA FY Cash from Operations2019-12-31: -$10.80M2020-12-31: -$25.57M2021-12-31: -$50.86M2022-12-31: -$93.79M2023-12-31: $139.80M2024-12-31: -$41.56M2025-12-31: -$128.51M$139.80M-$128.51M
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TRDA operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Entrada Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-128,512,000
-41,557,000
139,803,000
-93,786,000
-50,862,000
-25,570,000
-10,801,000

Compare operating cash flow (statement)

All TRDA financial metrics · TRDA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.